Venatorx Pharmaceuticals

Venatorx Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the discovery and development of innovative anti-infective agents aimed at addressing multi-drug-resistant (MDR) bacterial infections and challenging viral infections. Founded in 2010 and headquartered in Malvern, Pennsylvania, the company specializes in creating antibacterial drugs that target resistant pathogens, including those responsible for difficult-to-treat infections such as MRSA, Pseudomonas, and Salmonella. By employing novel chemical approaches, Venatorx develops treatments with selective and potent activity against various bacterial resistance mechanisms, thereby enhancing the therapeutic options available to healthcare professionals and addressing significant unmet medical needs in the field of infectious diseases.